FindTrial
Sign In

The application of Cetrorelix in prevention of early onset ovarian hyperstimulation syndrome in high response patients: a randomized controlled trial

The application of Cetrorelix in prevention of early onset ovarian hyperstimulation syndrome in high response patients: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15006210
Enrollment
Unknown
Registered
2015-04-08
Start date
2011-09-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian hyperstimulation syndrome

Interventions

intervention:gonadotrophin-releasing hormone antagonist
control:observation

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: high response patients in IVF-ET cycles, occyte retrieval number >35, or E2>20000pmol/L on hCG administration day

Exclusion criteria

Exclusion criteria: coagulation function abnormality, uterine cavity adhesion

Design outcomes

Primary

MeasureTime frame
incidence of OHSS;—

Secondary

MeasureTime frame
ovarian volume;blood index;—

Countries

China

Contacts

Public ContactYanghong Fan
13501056450@163.com+86 13501056450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026